Comparison of Different Promoter Methylation Assays in Breast Cancer

Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...

Full description

Bibliographic Details
Main Authors: Karijn P. M. Suijkerbuijk, Xiaojuan Pan, Elsken van der Wall, Paul J. van Diest, Marc Vooijs
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-CLO-2010-0542